DEFINING AND FUNCTIONALLY CHARACTERIZING THE EPIGENOME IN LETHAL PROSTATE CANCER...NEW GRANT, SIGNED 9/18/2019, EFFECTIVE 9/30/2019, DISTRIBUTED 9/19/2019, FAADC 9/19/2019
$794,379FY2019Defense Health AgencyDOD
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc.